Company profile
Finetech Medical Limited
Finetech Medical Active Implantable Medical Devices
Finetech Medical Limited is a UK company with status active founded in 1993 based in South East England.
Corporate ownership
Updated 06 Jun 2026 16:52
Latest accounts
Financial period: 1 Jan 2024 to 31 Dec 2024
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation Statement With No Updates
Confirmation-statementCS01 | Transaction MzUyNzM3Mjk2M2FkaXF6a2N4
Published 19 Jun 2026 18:41
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzQ1NjE3NTQ5MWFkaXF6a2N4
Published 24 Feb 2025 04:12
Accounts filed
AccountsLast accounts made up date
Accounts With Accounts Type Total Exemption Full
Accounts AnalysedAA | Transaction MzQzNjM4ODUwMmFkaXF6a2N4
Published 18 Sep 2024 13:00
Incorporated
InceptionCompany registered at Companies House
Spinout profile
Company description
Amber Therapeutics develops an implantable medical device to treat urinary incontinence using neuromodulation therapy.
Project impact
We have won a £1.1M Biomedical Catalyst grant and secured an additional £1M of venture capital investment for our seed round.
Public funding
Projects
Evolving the bionic bladder: supporting a sustainable transition to a next generation neurotechnology to restore bladder control following spinal cord injury
1 Dec 2020 to 28 Feb 2023
Injury or disease affecting the spinal cord or brain significantly affects how the bladder functions. It can destroy the ability to empty the bladder, cause unwanted contractions that lead to incontinence, and alter or remove the sensation that the bladder needs emptying. These dysfunctions require the use of catheters, can lead to frequent urinary tract ...
Improvements to implantable antennas
1 May 2011 to 31 Jul 2011
Awaiting Public Summary